Skip to main content
. 2015 Sep 25;6(37):40370–40384. doi: 10.18632/oncotarget.5458

Figure 4. Kaplan–Meier survival curves for recurrence-free survival A. and progression-free survival B. according to caldesmon (CAD) expression.

Figure 4

Expression was dichotomized appropriately according to the immunohistochemical score, which was based on staining area and intensity.